Last reviewed · How we verify

NCT06729216

Fungal Resistance in Dermatophyte Infection

Not yet recruiting Last updated 14 May 2025
What this trial tests

trial testing Antifungal susceptibility testing (AFST) in Dermatophyte Infection in 42 participants. Not yet recruiting.

Timeline
1 June 2025
Primary endpoint
1 July 2025
1 August 2025

Quick facts

Lead sponsorCairo University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment42
Start date1 June 2025
Primary completion1 July 2025
Estimated completion1 August 2025

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Eligibility, any sex, with Dermatophyte Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the efficiency of broth microdilution versus disk diffusion method for antifungal drug susceptibility testing of the most used drugs in dermatophytosis treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06729216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing